Other specified dermatitis
ICD-10 L30.8 is a billable code used to indicate a diagnosis of other specified dermatitis.
L30.8 refers to 'Other specified dermatitis,' which encompasses a variety of inflammatory skin conditions that do not fit neatly into more specific dermatitis categories. Clinically, patients may present with symptoms such as erythema, pruritus, scaling, and vesiculation, which can vary in severity. The anatomy involved primarily includes the epidermis and dermis, where inflammatory processes occur. Disease progression can be acute or chronic, often exacerbated by environmental factors, allergens, or irritants. Diagnostic considerations include a thorough patient history, physical examination, and, when necessary, skin biopsies or patch testing to identify specific triggers or underlying conditions. It is essential to differentiate L30.8 from other dermatitis codes, such as atopic dermatitis (L20) or contact dermatitis (L23-L24), to ensure accurate diagnosis and treatment.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L30.8 covers various dermatitis forms that do not fall under more specific categories, such as seborrheic dermatitis, nummular dermatitis, and certain drug-induced dermatitis. Each condition has distinct clinical features and may require specific diagnostic criteria for accurate coding.
L30.8 should be used when the dermatitis does not meet the criteria for more specific dermatitis codes. For instance, if a patient presents with dermatitis symptoms but the cause is not clearly identified as allergic or irritant, L30.8 is appropriate.
Documentation should include a detailed patient history, physical examination findings, and any diagnostic tests performed. Notes should clearly indicate the symptoms, duration, and any potential triggers or previous treatments to support the use of L30.8.
